References
- Gunter J. Genital and perianal warts: new treatment opportunities for human papillomavirus infection. Am J Obstet Gynecol. 2003; 189(3 Suppl): S3–S11.
- Gardasil® (quadrivalent human papillomavirus [types 6,11,16,18] recombinant vaccine) [package insert], Whitehouse Station, NJ: Merck and Co; 2008. http://www.gardasil.com/prescribe-gardasil/. Accessed October 17,2008.
- Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB, eds. Cancer incidence in 5 continents. Vol. 8. IRA Scientific Publication 155. Lyon, France: International Agency for Research on Cancer Scientific Publication no. 155. Lyon: IARC Press; 2002: 1–781.
- American Cancer Society. Cancer Facts and Figures 2008. http://www.cancer.org/docroot/STT/content/STT_lx_Cancer_Facts_and_Figures_2008.asp?from=fast. Accessed October 17,2008.
- Judson PL, Habermann EB, Baxter NN, Durham SB, Virnig BA. Trends in the incidence of invasive and in situ vulvar carcinoma. Obstet Gynecol. 2006; 107: 1018–1022.
- Hampl M, Sarajuuri H, Wentzensen N, Bender HG, Kueppers V. Effect of human papillomavirus vaccines on vulvar, vaginal, and anal intraepithelial lesions and vulvar cancer. Obstet Gynecol. 2006; 108(6): 1361–1368.
- Joura EA, Leodolter S, Hernandez-Avila M, et al. Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomized clinical trials. Lancet. 2007; 363(9574): 1693–1702.
- Villa LL, Costa RL, Petta CA, et al. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) LI virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol. 2005; 6(5): 271–278.
- Koutsky LA, Ault KA, Wheeler CM, et al. A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med. 2002; 347(21): 1645–1651.
- Garland SM, Hernandez-Avila M, Wheeler CM, et al. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N Engl J Med. 2007; 356(19): 1928–1943.
- FUTURE II Study Group. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med. 2007; 356(19): 1915–1927.
- US Food and Drug Administration. Information from CDC and FDA on the safety of Gardasil vaccine, http://www.fda.gov/cber/safety/gardasil071408.htm. Accessed October 17, 2008.
- Sutherland A, Izurieta H, Ball R, et al. Syncope after vaccination—Unites States, January 2005-July 2007. MMWR Morb Mortal WklyRep. 2008; 57(17): 457–460.
- Reuters UK. Merck's Gardasil not cleared for older women, http://uk.reuters.com/article/healthNews/idUKWNAS917720080626. June 25,2008. Accessed October 17, 2008.